ALLERGAN PREMIER Trademark

Trademark Overview

On Tuesday, April 14, 2020, a trademark application was filed for ALLERGAN PREMIER with the United States Patent and Trademark Office. The USPTO has given the ALLERGAN PREMIER trademark a serial number of 88870548. The federal status of this trademark filing is REGISTERED as of Tuesday, August 30, 2022. This trademark is owned by Allergan, Inc.. The ALLERGAN PREMIER trademark is filed in the Advertising, Business and Retail Services category with the following description:

Administration of a customer loyalty program that provides cash, financial incentives, and discounts towards the purchase of a company's pharmaceuticals and medical aesthetics products
allergan premier

General Information

Serial Number88870548
Word MarkALLERGAN PREMIER
Filing DateTuesday, April 14, 2020
Status700 - REGISTERED
Status DateTuesday, August 30, 2022
Registration Number6834449
Registration DateTuesday, August 30, 2022
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 2, 2021

Trademark Statements

Goods and ServicesAdministration of a customer loyalty program that provides cash, financial incentives, and discounts towards the purchase of a company's pharmaceuticals and medical aesthetics products
NOT AVAILABLE"PREMIER"

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, April 22, 2020
Primary Code035
First Use Anywhere DateFriday, February 28, 2020
First Use In Commerce DateFriday, February 28, 2020

Trademark Owner History

Party NameAllergan, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92612
US
Party NameAllergan, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIrvine, CA 92612
US
Party NameAllergan, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92612
US

Trademark Events

Event DateEvent Description
Friday, April 17, 2020NEW APPLICATION ENTERED
Wednesday, April 22, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 3, 2020ASSIGNED TO EXAMINER
Sunday, July 12, 2020EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Sunday, July 12, 2020COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Sunday, July 12, 2020EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Sunday, July 12, 2020NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Monday, January 11, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 11, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 12, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 27, 2021EXAMINERS AMENDMENT -WRITTEN
Wednesday, January 27, 2021EXAMINERS AMENDMENT E-MAILED
Wednesday, January 27, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, January 27, 2021EXAMINER'S AMENDMENT ENTERED
Wednesday, January 27, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 27, 2021ASSIGNED TO LIE
Wednesday, February 10, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 2, 2021PUBLISHED FOR OPPOSITION
Tuesday, March 2, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 27, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, October 15, 2021TEAS STATEMENT OF USE RECEIVED
Wednesday, November 3, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, October 15, 2021USE AMENDMENT FILED
Wednesday, November 3, 2021STATEMENT OF USE PROCESSING COMPLETE
Friday, November 26, 2021SU - NON-FINAL ACTION - WRITTEN
Friday, November 26, 2021NON-FINAL ACTION E-MAILED
Friday, November 26, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 26, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 31, 2022ASSIGNED TO LIE
Wednesday, June 1, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 1, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 22, 2022SU - FINAL REFUSAL - WRITTEN
Wednesday, June 22, 2022FINAL REFUSAL E-MAILED
Wednesday, June 22, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, July 25, 2022SU-EXAMINER'S AMENDMENT WRITTEN
Monday, July 25, 2022EXAMINERS AMENDMENT E-MAILED
Monday, July 25, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, July 25, 2022EXAMINER'S AMENDMENT ENTERED
Monday, July 25, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, July 26, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, August 30, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, August 30, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Monday, July 6, 2026TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 6, 2026ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 6, 2026TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 6, 2026TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

Related Keywords

premier allergan company purchase towards pharmaceuticals medical products aesthetics discounts incentives loyalty